SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

J Korean Med Sci. 2010;25(8):1146-51.

Emphysema as a risk factor for the outcome of surgical resection of lung cancer.

, , , , , , , , , ,

제1저자 이승아 · 교신저자 박주헌

소속 (1)
  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Abstract

It is unclear whether emphysema, regardless of airflow limitation, is a predictive factor associated with survival after lung cancer resection. Therefore, we investigated whether emphysema was a risk factor associated with the outcome after resection for lung cancer. This study enrolled 237 patients with non small cell lung cancer with stage I or II who had surgical removal. Patient outcome was analyzed based on emphysema. Emphysema was found in 43.4% of all patients. Patients with emphysema were predominantly men and smokers, and had a lower body mass index than the patients without emphysema. The patients without emphysema (n=133) survived longer (mean 51.2+/-3.0 vs. 40.6+/-3.1 months, P=0.042) than those with emphysema (n=104). The univariate analysis showed a younger age, higher FEV(1)/FVC, higher body mass index, cancer stage I, and a lower emphysema score were significant predictors of better survival. The multivariate analysis revealed a younger age, higher body mass index, and cancer stage I were independent parameters associated with better survival, however, emphysema was not. This study suggests that unfavorable outcomes after surgical resection of lung cancer should not be attributed to emphysema itself.

Keywords

EmphysemaNon-Small-Cell Lung CarcinomaSurgery

Figures

Fig. 1
Fig. 1 Kaplan-Meier curves for Survival of total Patients depending on the presence of emphysema (○emphysema (n=104), mean survival, 40.6±3.1 months; •non emphysema (n=133) mean survival, 51.2±3.0 months, P=0.042).
Fig. 2
Fig. 2 Kaplan-Meier curves for survival of NSCLC patients with stage I depending on the presence of emphysema (○emphysema (n=62), mean survival, 44.0±3.9 months; •non emphysema (n=97), mean survival, 57.9±3.1 months, P=0.036).
Fig. 3
Fig. 3 Survival of NSCLC Patients based on the degree of emphysema (Mean survival period of each group; Emp 0 (Grade 0, n=133), 51.2±3.0 months; Emp 1 (Grade 1, n=19), 41.7±7.6 months; Emp 2 (Grade 2, n=21), 41.1±5.7 months; Emp 3 (Grade 3, n=20), 44.2±6.8 months; Emp 4 (Grade 4, n=20), 26.3±7.1, P=0.07). Emp, emphysema.

그림 출처: PubMed Central 공개 논문 (PMC2908782)

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
Journal of Korean medical science · eISSN 1598-6357
전자 출판
2010-07-21
MeSH
Age Factors · Aged · Body Mass Index · Carcinoma, Non-Small-Cell Lung / complications / mortality / surgery · Emphysema / complications · Female · Humans · Lung Neoplasms / complications / mortality / surgery · Male · Middle Aged · Neoplasm Staging · Predictive Value of Tests · Risk Factors · Smoking · Survival Rate
참고문헌
28편